Meet Our Senior Executive Team

Our Executive Leadership

Alongside the Board of Directors, our Senior Executive Team (SET) is the group through which our Chief Executive Officer (CEO) carries out the authority the Board delegates. The CEO heads the SET and holds executive accountability for managing, developing and driving the performance of the business. The CEO, Chief Financial Officer and SET also lead the development of our strategy, which the Board reviews, constructively challenges and approves during our yearly strategy review.

Linda Zuckerman, Ph.D.

President & C.E.O

LinkedIn

Linda Zuckerman, Ph.D. brings more than 15 years of experience moving novel protein therapeutics, pharmaceuticals and medical devices from R&D through clinical trials and on to licensure with the FDA, EMA and other regulatory agencies. She has obtained approvals for several biologics and medical devices, and her background spans a broad range of indications, including oncology, autoimmunity and hemostasis.
As President and CEO of ID Genomics, Dr. Zuckerman now applies her deep drug development expertise to the global health challenge of antibiotic resistance, with the ultimate aim of delivering rapid, point-of-care diagnostic technologies that support accurate antibiotic prescribing across a wide range of microbial infections. Before joining ID Genomics, she served as CEO of Xcede Technologies, Inc. and President of ProFibrix Inc. Her career also includes leadership and scientific roles at ZymoGenetics and Genentech Inc.

Elena Rechkina, Ph.D.

Director of Lab Operations

LinkedIn

Dr. Rechkina has an extensive experience and broad scientific background in Molecular biology and has worked for over 7 years in industrial R&D of PCR diagnostics and production quality control.
Over the past six years she has worked with the Department of Microbiology at the University of Washington, Seattle, and with ID Genomics, where she grew into a leader in qPCR-based clonotyping, whole genome sequencing and analysis, single nucleotide polymorphism detection and multi locus sequence typing.

Sandy Ryan, RAC

Director for Administrative and Quality Assurance/Regulatory Affairs
LinkedIn

Ms. Ryan brings more than 12 years of experience across all phases of accounting, including administration of government grants and yearly and quarterly financial implementation, as well as oversight of quality and regulatory systems for a small IVD manufacturer. Her work covers development of Design History Files, Technical Files, document control systems and Device Master records, and she has led FDA inspections and ISO 13485 audits.

Veronika Tchesnokova, M.D., Ph.D.

Director of Research and Development

LinkedIn

Dr. Tchesnokova’s responsibilities include developing and implementing study designs, reporting, overseeing data integrity and quality control measures, performing statistical analysis of clinical and experimental data, and advising on all scientific engagements of the organization. She is also a research scientist in Microbiology at the University of Washington – School of Medicine and has co-authored 59 peer-reviewed publications.

Get to Know Our Board of Directors